Clinical Trial Update: Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

View source ↗

Summary

This clinical trial investigates switching from oral HIV therapy to a long-acting injectable regimen of cabotegravir plus rilpivirine; the study is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Patient Satisfaction, Patient Preference | Status: NOT_YET_RECRUITING